(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DAOGEST

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DAOGEST

ST13

US500000090309070

Class

1, 5

Filing

90309070

Registration

6840271

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

09/06/2022

Trademark type

Word

Nice classes

1, 5

Filing date

11/10/2020

Registration date

09/06/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/06/2022

Last transaction

09/06/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/08/2021

First use in commerce

03/08/2021

Drawing code

4

Owner type

99

Owner location

PALAFOLLS, ES

Examiner

SAITO, KIM

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOIBERICA, S.A.U.

Representatives

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

chemicals for use in industry and science; chemical preparations for use in photography; chemicals for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; biological preparations for use in industry and science; Diamine oxidase-based enzymes for use in the manufacture of dietary and functional foodsnutraceuticalsnutritional and food supplementspharmaceuticals for medical and veterinary usecosmetics; all of the above for the treatment of histamine intolerance and its associated symptomsmodulation of histamine imbalances and assists in the control of histamine derived from the diet

Class 5

pharmaceutical products and preparations for medical and veterinary use for the treatment of histamine intolerance and its associated symptomsmodulation of histamine imbalances and assists in the control of histamine derived from the diet; sanitary sterilizing preparations for medical use; dietetic food and dietetic preparations adapted for medical and veterinary use; Baby food; food supplements for people and animals; Disinfectants; diamine oxidase-based pharmaceuticals for the treatment of histamine intolerance and its associated symptomsmodulation of histamine imbalances and assistance in the control of histamine derived from the diet; diamine oxidase-based dietetic food and dietetic preparations adapted for medical use for the treatment of histamine intolerance and its associated symptomsmodulation of histamine imbalances and assistance in the control of histamine derived from the diet; diamine oxidase-based nutritional and food supplements for the treatment of histamine intolerance and its associated symptomsmodulation of histamine imbalances and assistance in the control of histamine derived from the diet

Publications

History of USPTO decisions and trademark events.

32 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/06/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/06/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/03/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/02/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/22/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/21/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/21/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/14/2022

GNRT

NON-FINAL ACTION E-MAILED

04/14/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/14/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/15/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/14/2022

IUAF

USE AMENDMENT FILED

01/27/2022

EISU

TEAS STATEMENT OF USE RECEIVED

01/27/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/13/2021

PUBO

PUBLISHED FOR OPPOSITION

07/13/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/23/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/09/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

06/09/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/09/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

06/09/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/09/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/08/2021

GNRT

NON-FINAL ACTION E-MAILED

05/08/2021

CNRT

NON-FINAL ACTION WRITTEN

05/08/2021

DOCK

ASSIGNED TO EXAMINER

04/19/2021

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

03/22/2021

ALIE

ASSIGNED TO LIE

03/18/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

12/16/2020

NWAP

NEW APPLICATION ENTERED

11/13/2020

Continuous trademark protection

Get notified about every new filing that threatens DAOGEST or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.